Covestor LTD Ultragenyx Pharmaceutical Inc. Transaction History

Covestor LTD

$181 Million
Q3 2025

A detailed history of Covestor LTD transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Covestor LTD holds 1,787 shares of RARE stock, worth $59,113. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,787

Previous 1,418 26.02%

Holding current value

$59,113

Previous $52,000 3.85%

% of portfolio

0.03%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	BUY	$26.31 - $41.44 $9,708 - $15,291	369 Added 26.02%	1,787 $54,000
Q2 2025 Aug 11, 2025	SELL	$31.06 - $39.3 $9,100 - $11,514	-293 Reduced 17.12%	1,418 $52,000
Q1 2025 May 12, 2025	BUY	$36.21 - $45.78 $28,786 - $36,395	795 Added 86.79%	1,711 $62,000
Q4 2024 Feb 13, 2025	BUY	$42.07 - $57.72 $9,465 - $12,987	225 Added 32.56%	916 $39,000
Q3 2024 Nov 01, 2024	BUY	$40.21 - $59.36 $80 - $118	2 Added 0.29%	691 $38,000

Q2 2024 Aug 09, 2024	SELL	$37.42 - $51.61 $11,450 - $15,792	-306 Reduced 30.75%	689 $28,000
Q1 2024 May 10, 2024	SELL	$43.02 - $53.69 $9,292 - $11,597	-216 Reduced 17.84%	995 $46,000
Q4 2023 Feb 09, 2024	BUY	$31.73 - $49.19 $14,690 - $22,774	463 Added 61.9%	1,211 $58,000
Q3 2023 Nov 13, 2023	BUY	$34.92 - $46.66 $20,812 - $27,809	596 Added 392.11%	748 $27,000
Q2 2023 Aug 11, 2023	BUY	$37.35 - $52.15 $821 - $1,147	22 Added 16.92%	152 $7,000
Q1 2023 May 15, 2023	BUY	$36.99 - $48.71 $36 - $48	1 Added 0.78%	130 $5,000
Q4 2022 Feb 13, 2023	SELL	$33.72 - $46.33 $1,348 - $1,853	-40 Reduced 23.67%	129 $5,000
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $1,798 - $2,976	45 Added 36.29%	169 $7,000
Q2 2022 Aug 10, 2022	SELL	$45.8 - $85.4 $45 - $85	-1 Reduced 0.8%	124 $7,000
Q1 2022 May 13, 2022	BUY	$62.2 - $84.4 $3,358 - $4,557	54 Added 76.06%	125 $9,000
Q4 2021 Feb 10, 2022	BUY	$73.71 - $87.86 $5,233 - $6,238	71 New	71 $6,000

Others Institutions Holding RARE

# of Institutions

348

Shares Held

88.2M

Call Options Held

2.19M

Put Options Held

1.04M

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.32B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account